New Drug Applications Archive - December 2010
Get news by email or subscribe to our news feeds.
December 2, 2010
December 3, 2010
- US FDA Advisory Committee Makes Recommendation on New Drug Application for Vandetanib in Advanced Medullary Thyroid Cancer
- Cell Therapeutics Files Appeal on FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
December 6, 2010
December 7, 2010
December 8, 2010
December 14, 2010
- Pacira Pharmaceuticals Announces FDA Acceptance of Exparel New Drug Application for Pain Management
- VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA
December 17, 2010
December 20, 2010
- Chelsea Therapeutics Accelerates Northera NDA Filing Following Meeting With FDA
- Fibrocell Science, Inc. Submits Complete Response to FDA Regarding Azficel-T
- King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for Acurox Tablets
- Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
December 21, 2010
December 22, 2010
- Antares Pharma Announces Filing of New Drug Application for Anturol for Overactive Bladder
- Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
- Abbott and AstraZeneca End License Agreement for the Development of Certriad
